Congressional Inquiry into Presidential Decision-Making Processes

The House Oversight Committee has intensified its investigation into former President Joe Biden's cognitive health and the administration's decision-making processes by issuing a subpoena to Anthony Bernal, a longtime senior advisor to former First Lady Jill Biden. Bernal is scheduled to appear for a deposition on July 16, 2025, after previously declining a voluntary interview despite the White House Counsel's Office waiving executive privilege for the committee's investigation.

Committee Chairman James Comer (R-Ky.) emphasized the importance of Bernal's testimony, citing his close working relationship with both the former President and First Lady. The committee seeks to determine whether senior aides concealed signs of President Biden's cognitive decline and whether executive actions were authorized without his direct involvement.

Testimonies and Allegations

Neera Tanden, former Director of the Domestic Policy Council and Staff Secretary under President Biden, testified before the committee in a closed-door session. Tanden confirmed she was authorized to use the autopen—a device that replicates the President's signature—for official documents between October 2021 and May 2023. She stated that while she had the authority to direct the autopen's use, she was unaware of who provided final approval for its deployment on specific documents.

The committee's investigation also includes testimonies from other former Biden administration officials. Dr. Kevin O'Connor, President Biden's former physician, has been subpoenaed to testify on July 9, 2025. Additionally, former White House aides Mike Donilon, Anita Dunn, Ron Klain, Bruce Reed, Steve Ricchetti, Annie Tomasini, and Ashley Williams have been identified as individuals of interest in the ongoing probe.

Political Context and Reactions

The investigation has garnered support from former President Donald Trump, who has waived executive privilege for nine former Biden administration officials, allowing them to testify before Congress. This move deviates from the traditional practice of former presidents upholding executive privilege to protect the confidentiality of their successors' administrations.

Democratic members of the committee have criticized the investigation as politically motivated. Representative Wesley Bell (D-Mo.) described the inquiry as an "extraordinary waste of time" that has yet to produce new evidence.

Broader Implications

The use of the autopen for signing official documents has been a standard practice in previous administrations. However, the committee's focus is on whether the device was used to authorize significant executive actions without President Biden's direct input, potentially raising questions about the legitimacy of those actions.

As the investigation continues, the committee aims to clarify the extent of President Biden's involvement in executive decisions during his tenure and whether any unauthorized actions were taken by senior aides without his knowledge or consent.